Earnings Feed
Start Free
Corbus Pharmaceuticals Holdings, Inc.·4

Jun 14, 4:24 PM ET

HOLMER ALAN F 4

4 · Corbus Pharmaceuticals Holdings, Inc. · Filed Jun 14, 2024

Insider Transaction Report

Form 4
Period: 2024-06-14
Corbus Pharmaceuticals Holdings, Inc.CRBP
HOLMER ALAN F
Director
Transactions
  • Exercise/Conversion

    Common Stock, par value $0.0001 per share

    2024-06-14$30.00/sh+1,667$50,010→ 5,829 total
  • Exercise/Conversion

    Options to purchase common stock

    2024-06-14−1,667→ 0 total
    Exercise: $30.00Exp: 2024-07-09→ Common Stock (1,667 underlying)
Footnotes (2)
  • [F1]This amount includes 2,783 unvested RSUs that were granted on May 30, 2024 and will vest 100% on the one-year anniversary from the date of grant.
  • [F2]The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan and is fully vested.

Documents

2 files